Vir Biotechnology(VIR) Stock Price Today

US Stock MarketDetailed Quotes

Vir Biotechnology (VIR)

Watchlist

8.500
+0.250+3.03%

Trading Jun 11 13:06 ET

1.43BMarket Cap-2.72P/E (TTM)

VIR Stock Chart

Real-Time

5D
Daily
Weekly
Monthly
1Q
1Y

VIR Orderflow

Unit: --

VIR Orderflow Trend

IntradayDayWeekMonth

No Data

Vir Biotechnology (VIR) News

Morgan Stanley Maintains Vir Biotechnology(VIR.US) With Buy Rating, Raises Target Price to $27
Moomoo NewsJun 11 08:33 ET · Ratings
Express News | Morgan Stanley Maintains Overweight on Vir Biotechnology, Raises Price Target to $27
BenzingaJun 11 08:30 ET
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Sutro Biopharma (STRO) and Ardent Health Partners, Inc. (ARDT)
TipRanksJun 11 07:53 ET · Ratings
Mirum Pharmaceuticals Price Target Raised to $150 From $140 at Morgan Stanley
TipRanksJun 11 07:25 ET
Express News | Vir Biotechnology Inc : Morgan Stanley Raises Target Price to $27.00 From $23.00
ReutersJun 11 06:53 ET
Vir Biotechnology Announces Appointment of Timothy Coughlin to Its Board of Directors
Vir BiotechnologyJun 10 00:00 ET

Vir Biotechnology (VIR) Stock Forum

Trytosaveabit

Apr 16 20:10

news

$Vir Biotechnology (VIR.US)$ Reuters
3m
Vir Biotechnology Announces Closing of Global Strategic Collaboration With Astellas for the Treatment of Prostate Cancer! Receives $240 Mln Upfront and $75 Mln Equity Investment at $10.36 per Share

DrJaguar8

Apr 16 20:07

NEWS

$Vir Biotechnology (VIR.US)$
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
by Business Wire
Follow
- Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues
- Astellas to lead commercialization of VIR-5500 in the U.S. with Vir Biotechnology retaining option to co-promote, and Astellas obtaining exclusive rights to commercialize VIR-5500 ex-U.S.
Vir Bi...